1. Home
  2. 2024-07-09
  3. 2024-07-08
  4. 2024-07-07
  5. 2024-07-06
  6. 2019-07-18
  7. 2021-04-07
  8. 2021-04-13
  9. 2020-08-04
  10. 2020-04-18
  11. 2020-12-26
  1. Home
  2. aj minter haircut
  3. Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C

4.9
(191)
$ 9.00 In stock

Product Description

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Molecules, Free Full-Text
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Delivery of cancer therapies by synthetic and bio-inspired nanovectors, Molecular Cancer
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Doxorubicin-conjugated β-NaYF4:Gd3+/Tb3+ multifunctional, phosphor nanorods: a multi-modal, luminescent, magnetic probe for simultaneous optical and magnetic resonance imaging and an excellent pH-triggered anti-cancer drug delivery nanovehicle
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Nanomaterials, Free Full-Text
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Molecules, Free Full-Text
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
New approaches to molecular cancer therapeutics
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Controlled drug delivery vehicles for cancer treatment and their performance
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Nanomaterials, Free Full-Text

Related products

You may also like

copyright © 2019-2024 gilanifoundation.com all rights reserved.